Myc/Bcl6 double hit lymphoma negative for T(3;8) Bcl6::Myc fusion Is associated with inferior survival, in contrast with T(3;8) positive pseudo‐double hit lymphoma
Abstract
MYC/BCL6 DOUBLE HIT LYMPHOMA NEGATIVE FOR T(3;8) BCL6::MYC FUSION IS ASSOCIATED WITH INFERIOR SURVIVAL, IN CONTRAST WITH T(3;8) POSITIVE PSEUDO-DOUBLE HIT LYMPHOMA B Introduction: b A small proportion of large B cell non-Hodgkin lymphoma (NHL) has I MYC i and I BCL6 i rearrangements, detectable by fluorescence in-situ hybridisation (FISH) break-apart probes. Cases of I MYC/BCL2 i double-hit lymphoma without I BCL6 i rearrangement were excluded.
Citations
Altmetric:
Date
2023-06
Type
Article
Subject
Haematology, Oncology. Pathology.
Citation
Maybury, BD, James, L, Chadderton, N, Dowds, J, Venkatadasari, I, Riley, J, Qureshi, I, Talbot, G, Giles, HV, Phillips, NJ, Gonzalez, MV, Rakesh, P, Haslam, A, Davies, D, Moosai, S, Lane, SA, Shenouda, A, Cherian, GV, Kaudlay, PK & Starczynski, J 2023, ‘Myc/Bcl6 Double Hit Lymphoma Negative for T(3;8) Bcl6::Myc Fusion Is Associated with Inferior Survival, in Contrast with T(3;8) Positive Pseudo‐Double Hit Lymphoma’, Hematological Oncology, vol. 41, pp. 205–207.
Journal / Source Title
Hematological Oncology
DOI
10.1002/hon.3163_134
PMID
Publisher
Wiley